{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:33:35Z","timestamp":1762432415345,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":292,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021510","name":"Department of Haematology, Christian Medical College, Vellore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.lrr.2023.100393","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T11:18:06Z","timestamp":1697887086000},"page":"100393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-7762","authenticated-orcid":false,"given":"A-M Jo\u00eblle","family":"Marivel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anvita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Trieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara L.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia C.W.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lrr.2023.100393_bib0001","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1038\/s41467-021-23394-4","article-title":"Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer","volume":"12","author":"Pereira","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lrr.2023.100393_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-020-01601-2","article-title":"Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples","volume":"39","author":"Russano","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lrr.2023.100393_bib0003","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41416-021-01594-5","article-title":"Cell-free DNA technologies for the analysis of brain cancer","volume":"126","author":"Mair","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.lrr.2023.100393_bib0004","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1097\/HS9.0000000000000710","article-title":"This Is Going to Hurt: revisiting the Patient Experience of Bone Marrow Biopsies","volume":"6","author":"Hibbs","year":"2022","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.lrr.2023.100393_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41408-023-00796-9","article-title":"Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma","volume":"13","author":"Mithraprabhu","year":"2023","journal-title":"Blood Cancer J."},{"issue":"8","key":"10.1016\/j.lrr.2023.100393_bib0006","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.lrr.2023.100393_bib0007","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.1177","article-title":"High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis","volume":"18","author":"Bezieau","year":"2001","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.lrr.2023.100393_bib0008","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/2159-8290.CD-13-0297","article-title":"Targeting BRAF in multiple myeloma","volume":"3","author":"O'Donnell","year":"2013","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.lrr.2023.100393_bib0009","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/annonc\/mdx112","article-title":"Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer","volume":"28","author":"Grasselli","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lrr.2023.100393_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lungcan.2019.06.021","article-title":"The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a prospective study","volume":"134","author":"Ding","year":"2019","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.lrr.2023.100393_bib0011","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jmoldx.2021.03.001","article-title":"Clinical experience of cerebrospinal fluid-based liquid biopsy demonstrates superiority of cell-free DNA over cell pellet genomic DNA for molecular profiling","volume":"23","author":"Bale","year":"2021","journal-title":"J. Mol. Diagn."},{"issue":"4","key":"10.1016\/j.lrr.2023.100393_bib0012","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1097\/HS9.0000000000000402","article-title":"Limits and applications of genomic analysis of circulating tumor DNA as a liquid biopsy in asymptomatic forms of multiple myeloma","volume":"4","author":"Manzoni","year":"2020","journal-title":"Hemasphere"},{"issue":"26","key":"10.1016\/j.lrr.2023.100393_bib0013","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lrr.2023.100393_bib0014","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/ijc.28946","article-title":"Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer","volume":"135","author":"Spindler","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.lrr.2023.100393_bib0015","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/bloodadvances.2019001156","article-title":"Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia","volume":"4","author":"Short","year":"2020","journal-title":"Blood Adv."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892300033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892300033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:09:05Z","timestamp":1761959345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221304892300033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":15,"alternative-id":["S221304892300033X"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2023.100393","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2023.100393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100393"}}